<code id='9BBF0B5016'></code><style id='9BBF0B5016'></style>
    • <acronym id='9BBF0B5016'></acronym>
      <center id='9BBF0B5016'><center id='9BBF0B5016'><tfoot id='9BBF0B5016'></tfoot></center><abbr id='9BBF0B5016'><dir id='9BBF0B5016'><tfoot id='9BBF0B5016'></tfoot><noframes id='9BBF0B5016'>

    • <optgroup id='9BBF0B5016'><strike id='9BBF0B5016'><sup id='9BBF0B5016'></sup></strike><code id='9BBF0B5016'></code></optgroup>
        1. <b id='9BBF0B5016'><label id='9BBF0B5016'><select id='9BBF0B5016'><dt id='9BBF0B5016'><span id='9BBF0B5016'></span></dt></select></label></b><u id='9BBF0B5016'></u>
          <i id='9BBF0B5016'><strike id='9BBF0B5016'><tt id='9BBF0B5016'><pre id='9BBF0B5016'></pre></tt></strike></i>

          leisure time

          leisure time

          author:focus    Page View:66494
          A sign of Humana insurance company on a brick building — business coverage from STAT
          Adobe

          Medicare Advantage beneficiaries on Tuesday filed a class-action lawsuit alleging that the health insurance giant Humana illegally used an algorithm to prematurely cut off payment for rehabilitation care after patients suffered serious illnesses and injuries.

          The suit, filed in U.S. District Court in Western Kentucky, argues Humana’s reliance on the algorithm, known as nH Predict, was part of a fraudulent scheme to reap a windfall by systematically denying claims to desperately ill people.

          advertisement

          It is the second suit filed following a STAT investigation that found Medicare Advantage insurers nationwide are using the algorithm to cut off patients’ rehab care, forcing them to forgo treatment or pay thousands of dollars out of pocket. An earlier complaint was filed in November against the algorithm’s maker, NaviHealth, and the company that owns NaviHealth, UnitedHealth Group.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          Fed up with FDA, ALS advocates consider a take
          Fed up with FDA, ALS advocates consider a take

          Ademonstrationmarkingthe10thanniversaryoftheformationACTUP,inNewYork.MarkLennihan/APWASHINGTON—NextW

          read more
          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more

          How the messy conversation about Dolly changed bioethics

          SophieGogginsoftheNationalMuseumsScotlandinEdinburghviewsDollytheSheepduringtheopeningofamajornewdev